Dr. Karamjeet Sandhu, M.D.
Claim this profileCity of Hope Medical Center
Studies Acute Myeloid Leukemia
Studies Hematological Malignancies
5 reported clinical trials
7 drugs studied
Area of expertise
1Acute Myeloid Leukemia
CD33 positive
HLA-A positive
HLA-A negative
2Hematological Malignancies
HLA-A positive
HLA-A negative
HLA positive
Affiliated Hospitals
Clinical Trials Karamjeet Sandhu, M.D. is currently running
Human Lysozyme Goat Milk
for Blood Cancer Post-Transplant Care
This phase I trial studies the side effects of human lysozyme goat milk in preventing graft versus host disease in patients with blood cancer undergoing a donor stem cell transplant. Sometimes the transplanted cells from a donor can cause an immune response against the body's own normal cells (call graft versus host disease). The goat milk in the study is from goats that have been genetically engineered to produce human lysozyme in the milk. Human lysozyme is a natural enzyme found in human milk and acts as an antimicrobial. Lysozyme is key to the digestive health of breast-fed human infants, since it helps the growth of beneficial gut bacteria and reduces the growth of bacteria that causes diarrhea and intestinal disease. Giving human lysozyme goat milk may reduce the rate of graft versus host disease in blood cancer patients undergoing a donor stem cell transplant.
Recruiting2 awards Phase 114 criteria
CAR T-Cell Therapy
for Acute Myeloid Leukemia
This trial tests a new treatment where immune cells are modified to better attack leukemia cells. It targets patients whose leukemia has returned or is resistant to other treatments. The modified immune cells are designed to specifically recognize and kill cancer cells.
Recruiting1 award Phase 1
More about Karamjeet Sandhu, M.D.
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Karamjeet Sandhu, M.D. has experience with
- Anti-CD33 CAR T-cells
- Lymphodepletion Therapy
- Human Lysozyme Goat Milk
- Electron Beam Radiotherapy
- B. Infantis (PBCLN-014)
- Human Milk Oligosaccharides (HMO) (PBCLN-010)
Breakdown of trials Karamjeet Sandhu, M.D. has run
Acute Myeloid Leukemia
Hematological Malignancies
Blood Cancers
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karamjeet Sandhu, M.D. specialize in?
Karamjeet Sandhu, M.D. focuses on Acute Myeloid Leukemia and Hematological Malignancies. In particular, much of their work with Acute Myeloid Leukemia has involved CD33 positive patients, or patients who are HLA-A positive.
Is Karamjeet Sandhu, M.D. currently recruiting for clinical trials?
Yes, Karamjeet Sandhu, M.D. is currently recruiting for 2 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Karamjeet Sandhu, M.D. has studied deeply?
Yes, Karamjeet Sandhu, M.D. has studied treatments such as Anti-CD33 CAR T-cells, Lymphodepletion Therapy, Human Lysozyme Goat Milk.
What is the best way to schedule an appointment with Karamjeet Sandhu, M.D.?
Apply for one of the trials that Karamjeet Sandhu, M.D. is conducting.
What is the office address of Karamjeet Sandhu, M.D.?
The office of Karamjeet Sandhu, M.D. is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.